Three-weekly doses of azithromycin for Indigenous infants hospitalised with bronchiolitis: A multicentre, randomised, placebo-controlled trial

Three-weekly doses of azithromycin for Indigenous infants hospitalised with bronchiolitis: A multicentre, randomised, placebo-controlled trial

Background Bronchiolitis is a major health burden in infants globally, particularly among Indigenous populations. It is unknown if 3-weeks of azithromycin improve clinical outcomes beyond the hospitalisation period. In an international, double-blind randomised controlled trial, we determined if 3-we...

Full description

Bibliographic Details
Main Authors: Gabrielle Britt McCallum, Peter S Morris, Keith eGrimwood, Carolyn eMaclennan, Andrew V White, Mark D Chatfield, Theo P Sloots, Ian M Mackay, Heidi eSmith-Vaughan, Clare C Mckay, Lesley A Versteegh, Nerida eJacobsen, Charmaine eMobberley, Catherine Ann Byrnes, Anne B Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-04-01
Series:Frontiers in Pediatrics
Subjects:
Azithromycin
Bacteria
Bronchiolitis
Macrolides
Viruses
respiratory syncytial virus
Online Access:http://journal.frontiersin.org/Journal/10.3389/fped.2015.00032/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fped.2015.00032/full

Similar Items